Back
Speaker illustration

Doctor Pieter Gerard Postema

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

Member of:

European Society of Cardiology
European Heart Rythm Association

Dr. Postema received his MD cum laude from the Free University Amsterdam, The Netherlands, in 2005, and his PhD cum laude from the University of Amsterdam in 2010. After postgraduate cardiology training in 2015 at the Amsterdam Academic Medical Center, he joined staff in 2017 as associate professor and fully EHRA certified cardiologist-electrophysiologist in both implantable devices (ECDS) as well as invasive electrophysiology (ECES). Alongside caring for cardiology patients, Dr. Postema is involved in many research projects in both pre-clinical elements of ventricular arrhythmia (including genetics and pre-clinical models), and in clinical evaluations and treatment of both rare and acquired ventricular arrhythmia (e.g. inheritable syndromes or myocardial ischemia). This research includes sophisticated (non-)invasive studies of cardiac electrophysiology often in combination with other clinical and/or pre-clinical specialists in strong national and international collaborations.

Presentations Articles Podcasts

Genetics of SCD: from rare and common variants to polygenic risk scores

Event: EHRA 2023

Topic: Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Session: Basic Science 2 - Finding novel targets for ventricular arrhythmias and SCD

Access
Thumbnail

Genetic predisposition to atrial and ventricular arrhythmias: beyond classical inherited arrhythmia syndromes.

Event: ESC Congress 2022

Topic: Cardiac Diseases

Session: How do common genetic variants cause cardiac diseases?

Access
Thumbnail

How to detect and prevent drug induced Brugada syndrome.

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: ECG (Cardiac arrhythmias, non invasive)

Session: Electrocardiogram, Holter recordings and remote monitoring for preventing malignant ventricular arrhythmias

Access
Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb